MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Untargeted Serum Metabolomics Identifies Glycine-Serine Metabolism Disruption as Biochemical Bignature in Parkinson’s Disease

    A. Imarisio, C. Marino, M. Avenali, G. Buongarzone, M. Picascia, T. Nuzzo, C. Gasparri, F. Errico, M. Grimaldi, MC. Monti, A. Filosa, M. Rondanelli, C. Pacchetti, AM. D'Ursi, A. Usiello, EM. Valente (Pavia, Italy)

    Objective: We attempted to identify a metabolomic signature distinctive of Parkinson’s disease (PD) through an untargeted metabolomics approach. Background: Using an high-performance liquid chromatography targeted…
  • 2024 International Congress

    The Impact of Drug Interactions on the results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes

    I. Kang, D. Bega (Chicago, USA)

    Objective: This study was a retrospective chart review of patients who underwent DAT-SPECT imaging for parkinsonism while on drugs listed as potentially interacting with the…
  • 2024 International Congress

    Longitudinal change in brain function and structure related to plasma neurofilament light protein in early-stage Parkinson’s disease

    Y. Xiao, SC. Wang, YB. Hou, HF. Shang (Chengdu, China)

    Objective: We aimed to explore the relationship between the pNfL and change in the brain in early-stage PD using a longitudinal brain imaging cohort. Background:…
  • 2024 International Congress

    Impact of Altered Cerebrovascular Reactivity on Midbrain Degeneration, Perfusion and White Matter

    N. Hoffman, S. Nitschke, K. Julio, N. Shaff, A. Dodd, G. Suarez Cedeno, A. Deligtisch, D. Sugar, E. Erhardt, H. Lin, A. Vakhtin, H. Van-Der-Horn, S. Pirio Richardson, A. Mayer, S. Ryman (Albuquerque, USA)

    Objective: To evaluate whether altered cerebrovascular reactivity contributes to midbrain degeneration, perfusion abnormalities, or white matter disease in patients with Parkinson’s disease (PD). Background: Cerebrovascular…
  • 2024 International Congress

    Dopaminergic denervation and focal motor progression in early Parkinson’s Disease: A 5-year longitudinal study

    MA. Ruiz Yanzi, M. Matarazzo, JA. Pineda-Pardo, T. Jiménez-Castellanos, MHG. Monje, A. Sánchez-Ferro, R. Martínez-Fernández, C. Gasca-Salas, JA. Obeso (Madrid, Spain)

    Objective: To evaluate the progression of posterior putamen dopaminergic denervation in relation to motor progression in the less affected and more affected side of the…
  • 2024 International Congress

    Sex Cerebral Vasoreactivity Differences in Parkinson’s Disease: Uncovering the Tip of the Iceberg

    M. Cansino Torres, D. Ortiz Zacarias, A. Rodríguez Martínez, J. Trejo Ayala, S. Castillo Torres, F. Góngora Rivera, B. Chávez Luévanos, I. Estrada Bellman (Monterrey, Mexico)

    Objective: To determine sex differences in cerebral vasoreactivity (cVR) in patients with Parkinson’s disease (PD) and its association with the clinical spectrum of the disease.…
  • 2024 International Congress

    Is GPI DBS as effective to STN DBS for tremor control in Parkinson’s disease?

    A. Prabhu, C. Reddy, K. Pillai, H. Chovatiya, M. Chacko, A. Avarachan, A. Kishore (Kochi, India)

    Objective: To compare the benefits of GPI and STN DBS on tremor in Parkinson’s disease (PD). Background: DBS is a highly effective surgical therapy for…
  • 2024 International Congress

    Do differences in risk aversion and perceived social support contribute to gender disparities in deep brain stimulation utilization in Parkinson’s disease

    B. Heffernan, S. Sillau, M. Sleyster, M. Fullard (Aurora, USA)

    Objective: To examine gender differences in risk tolerance in Parkinson’s disease and to determine factors associated with risk tolerance. Background: Deep brain stimulation (DBS) is…
  • 2024 International Congress

    Viability and Accuracy of Visual Estimation in Determining Directional Deep Brain Stimulation Lead Orientation

    GA. Brandt, C. Vander Linden, C. Schedlich-Teufer, V. Visser-Vandevalle, MT. Barbe, TA. Dembek (Köln, Germany)

    Objective: To assess the viability and accuracy of visual estimation in determining directional deep brain stimulation (DBS) lead orientation. Background: Directional DBS leads show large…
  • 2024 International Congress

    The Current State of Wearable Device Use in Parkinson’s Disease (A Survey of Individuals with Parkinson’s and Specialist Clinicians)

    S. Hirczy, Y. Lin, C. Zabetian (Seattle, USA)

    Objective: To develop a better understanding of the current use of consumer and medical wearable monitoring devices in the clinical management of PD and to…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley